| 1 |
34044856 | Changing trends in lipid profile and biomarkers of renal function and bone metabolism before and after switching from tenofovir disoproxil fumarate to tenofovir alafenamide: a prospective observational study. | 2021 May 27 |
2 |
| 2 |
34526412 | Clinical evaluation of urinary liver-type fatty acid-binding protein for the diagnosis of renal diseases in dogs. | 2021 Sep 27 |
2 |
| 3 |
35083252 | Hemodynamics and Metabolic Parameters in Normothermic Kidney Preservation Are Linked With Donor Factors, Perfusate Cells, and Cytokines. | 2021 |
1 |
| 4 |
32038102 | Circulating fatty acid-binding protein 1 (FABP1) and nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus. | 2020 |
1 |
| 5 |
32050627 | Urinary Liver-Type Fatty-Acid-Binding Protein Predicts Long-Term Adverse Outcomes in Medical Cardiac Intensive Care Units. | 2020 Feb 10 |
1 |
| 6 |
32155236 | Increased Urinary Liver-Type Fatty Acid-Binding Protein Level Predicts Major Adverse Cardiovascular Events in Patients With Hypertension. | 2020 Jul 18 |
1 |
| 7 |
31470789 | Clinical significance of urinary L-FABP in the emergency department. | 2019 Aug 30 |
1 |
| 8 |
31583093 | Disrupted tubular parathyroid hormone/parathyroid hormone receptor signaling and damaged tubular cell viability possibly trigger postsurgical kidney injury in patients with advanced hyperparathyroidism. | 2019 Oct |
1 |
| 9 |
30026130 | Increased Urinary Liver-Type Fatty Acid-Binding Protein Level Predicts Worsening Renal Function in Patients With Acute Heart Failure. | 2018 Aug |
1 |
| 10 |
28197733 | Relationship between exercise capacity and urinary liver-type fatty acid-binding protein in middle-aged and older individuals. | 2017 Oct |
2 |
| 11 |
28571184 | The Importance of Liver-Fatty Acid Binding Protein in Diagnosis of Liver Damage in Patients with Acute Hepatitis. | 2017 Apr |
1 |
| 12 |
27330813 | Comparison of three early biomarkers for acute kidney injury after cardiac surgery under cardiopulmonary bypass. | 2016 |
1 |
| 13 |
24626813 | Level of urinary liver-type fatty acid-binding protein is associated with cardiac markers and electrocardiographic abnormalities in type-2 diabetes with chronic kidney disease stage G1 and G2. | 2015 May |
1 |
| 14 |
25229339 | Urinary L-FABP predicts poor outcomes in critically ill patients with early acute kidney injury. | 2015 Mar |
1 |
| 15 |
26010898 | Distinct roles of urinary liver-type fatty acid-binding protein in non-diabetic patients with anemia. | 2015 |
1 |
| 16 |
26316797 | Elevation of urinary liver-type fatty acid binding protein after cardiac catheterization related to cardiovascular events. | 2015 |
1 |
| 17 |
26628791 | Clinical significance of urinary liver-type fatty acid binding protein at various stages of nephropathy. | 2015 Sep-Oct |
1 |
| 18 |
24164392 | Urine liver-type fatty acid-binding protein and kidney injury molecule-1 in HIV-infected patients receiving combined antiretroviral treatment based on tenofovir. | 2014 Apr |
2 |
| 19 |
24582841 | Low levels of urinary liver-type fatty acid-binding protein may indicate a lack of kidney protection during aortic arch surgery requiring hypothermic circulatory arrest. | 2014 Mar |
2 |
| 20 |
24800492 | [L-type fatty acid binding protein (L-FABP) and kidney disease]. | 2014 Feb |
1 |
| 21 |
25271041 | Mortality prediction by acute kidney injury biomarkers in comparison with serum creatinine. | 2014 Dec |
1 |
| 22 |
23378622 | Urinary liver-type fatty acid-binding protein and progression of diabetic nephropathy in type 1 diabetes. | 2013 Jul |
1 |
| 23 |
23407997 | L-FABP can be an early marker of acute kidney injury in children. | 2013 Jun |
1 |
| 24 |
21673461 | Potential benefit of statin therapy for dyslipidemia with chronic kidney disease: Fluvastatin Renal Evaluation Trial (FRET). | 2011 |
3 |
| 25 |
21996226 | Liver fatty-acid-binding protein in heart and kidney allograft recipients in relation to kidney function. | 2011 Oct |
1 |
| 26 |
19940842 | Urinary liver-type fatty acid-binding protein predicts adverse outcomes in acute kidney injury. | 2010 Apr |
1 |
| 27 |
20185732 | Urinary liver-type fatty acid-binding protein predicts progression to nephropathy in type 1 diabetic patients. | 2010 Jun |
1 |
| 28 |
19502542 | Tubular and glomerular injury in diabetes and the impact of ACE inhibition. | 2009 Sep |
1 |
| 29 |
18094680 | Liver fatty acid-binding protein as a biomarker of acute kidney injury after cardiac surgery. | 2008 Feb |
1 |
| 30 |
17954367 | Beneficial effects of olmesartan and temocapril on urinary liver-type fatty acid-binding protein levels in normotensive patients with immunoglobin A nephropathy. | 2007 Nov |
2 |
| 31 |
16490622 | Urinary excretion of liver-type fatty acid-binding protein in contrast medium-induced nephropathy. | 2006 Mar |
1 |
| 32 |
16532260 | Urinary liver-type fatty acid binding protein as a useful biomarker in chronic kidney disease. | 2006 Mar |
1 |
| 33 |
16534182 | Effect of pitavastatin on urinary liver-type fatty-acid-binding protein in patients with nondiabetic mild chronic kidney disease. | 2006 |
2 |
| 34 |
15830271 | Urinary excretion of liver fatty acid-binding protein in health-check participants. | 2005 Mar |
2 |
| 35 |
15871303 | Clinical evaluation of urinary excretion of liver-type fatty acid-binding protein as a marker for the monitoring of chronic kidney disease: a multicenter trial. | 2005 Mar |
3 |
| 36 |
15970406 | Quantification of L-type fatty acid binding protein in the urine of preterm neonates. | 2005 Jul |
1 |
| 37 |
16249547 | Effect of pitavastatin on urinary liver-type fatty acid-binding protein levels in patients with early diabetic nephropathy. | 2005 Nov |
4 |
| 38 |
14749682 | Urinary fatty acid-binding protein as a new clinical marker of the progression of chronic renal disease. | 2004 Jan |
2 |
| 39 |
12707994 | [Urinary fatty acid binding protein as a new clinical marker for the progression of chronic renal disease]. | 2003 Mar |
1 |